Previous 10 | Next 10 |
Hoegh LNG Partners LP (HMLP) -63% slashes dividend by ~98% to $0.01 per share.Alset EHome International Inc. (AEI) -34% after secures $32M capital raiseSGOCO Group, Ltd. (SGOC) -11%.Teladoc Health, Inc. (TDOC) -9% on Q2 earnings releaseXenetic Biosciences, Inc. (...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Xenetic Biosciences Inc Surges Amid $12.5 Million Private Stock Sale” Xenetic Biosciences Inc (NASDAQ: XBIO) climbed over 29% in premarket trading after the compan...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Xenetic Biosciences (NASDAQ: XBIO ) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a p...
Gainers: Tyme Technologies (TYME) +64%.Bit Digital (BTBT) +49%.SPAR Group (SGRP) +41%.Xenetic Biosciences (XBIO) +26%.IMV (IMV) +25%.Studio City International Holdings (MSC) +25%.Bitfarms (BITF) +24%.MicroStrategy (MSTR) +22%.Riot Blockchain (RIOT) +21%.RBC Bearings (ROLL) +19%.Losers: Iterum...
3 Hot Biotech Penny Stocks to Watch in 2021 Biotech penny stocks are heating up, and it doesn’t look like the momentum is going anywhere anytime soon. The momentum around penny stocks in the biotech industry began early last year as the pandemic set in. And while it started w...
Gainers: Tyme Technologies TYME +46%, Xenetic Biosciences XBIO +40%, IMV (IMV) +18%, Translate Bio (TBIO) +10%, Reviva Pharmaceuticals (RVPH) +9%.Losers: ATI Physical Therapy ATIP -40%, Iterum Therapeutics ITRM -36%, Intec Pharm...
IMV (IMV) +51%.Tyme Technologies (TYME) +35% granted U.S. patent claims covering use of Tyrosine-based drug delivery method to treat cancerDynatronics (DYNT) +33%.NanoVibronix (NAOV) +33%.Xenetic Biosciences (XBIO) +35% on $12.5M private placementBitfarms (BITF) +19%.Bit ...
FRAMINGHAM, MA / ACCESSWIRE / July 26, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today ann...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Xenetic Biosciences (NASDAQ: XBIO ) is flying high today, although at first glance, you might not know why. The small cap biotech play doesn’t have much in the way of news to report. So, what is causing XBI...
Why These 3 Penny Stocks Shot Up on Friday When looking for penny stocks to buy, finding the biggest daily gainers is a very common strategy. This allows investors to seek out companies that could have forward momentum or ones that could be gaining for speculative reasons. However, ...
News, Short Squeeze, Breakout and More Instantly...
Xenetic Biosciences Inc. Company Name:
XBIO Stock Symbol:
NASDAQ Market:
Xenetic Biosciences Inc. Website:
Company's Board of Directors Appoint James F. Parslow to Interim Chief Executive Officer FRAMINGHAM, MA / ACCESSWIRE / May 22, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technolog...
Ongoing preclinical studies with multiple data readouts expected throughout remainder of 2024 Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Ended the qu...
Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Ended the year with $9.0 million of cash to fund operations FRAMINGHAM, MA / ACCESSWIRE / March 22, 2024 /...